Nonalcoholic steatohepatitis (NASH) is a chronic liver disease causing hepatocellular injury and inflammation due to the accumulation of fat.
NASH is an inflammatory sub...
Most patients with NAFLD and NASH are asymptomatic.
In symptomatic patients, malaise, fatigue, nausea, and right upper quadrant discomfort are most common.
Review history for comorbid c...
Weight loss of at least 5-7% of body weight helps stabilize steatosis. Greater...
All patients should be tested for hepatitis A and B and vaccinated, if not immune.
Consider screening patients with NASH cirrhosis for hepatocellular carcinoma acc...
Leoni S, Tovoli F, Napoli L, et al. Current guidelines for the management of non- alcoholic fatty liver disease: a systematic review with comparative analysis. ...
K75.81 Nonalcoholic steatohepatitis (NASH)
K76.0 Fatty (change of) liver, not elsewhere classified
442685003 nonalcoholic steatohepatitis (disorder)
197315008 Non-alcoholic fatty liver (...
The prevalence of NAFLD and NASH is higher in patients with metabolic syndrome or any one of its components (diabetes, obesity, hypertriglyceridemia).
Liver biopsy is the gold standard ...
Sign up for a 10-day FREE Trial now and receive full access to all content.